The Oncology Institute News

DEFA14A: Others

May 2 17:02 ET

DEF 14A: Definitive information statements

May 2 17:00 ET

ARS: Annual Report to Security Holders

Apr 26 15:15 ET

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 22 16:37 ET

10-K/A: Annual report (Amendment)

Apr 22 16:32 ET

The Oncology Institute | 8-K: Current report

Apr 3 16:03 ET

The Oncology Institute | 10-K: Annual report

Mar 28 06:49 ET

The Oncology Institute | 8-K: The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024

Mar 27 16:10 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.

Jan 30 19:08 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.

Jan 26 19:20 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.

Jan 23 00:00 ET

The Oncology Institute | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 19 00:00 ET

The Oncology Institute | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Havencrest Healthcare Partners GP, LLC(12.04%),Havencrest Healthcare Partners, L.P.(11.93%), etc.

Jan 2 00:00 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-10% Owner Havencrest Healthcare Partners, L.P.

Jan 2 00:00 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director BARASCH RICHARD A

Dec 28, 2023 00:00 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Hively Brad

Dec 28, 2023 00:00 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Johnson Karen Marie

Dec 28, 2023 00:00 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Kaushal Mohit

Dec 28, 2023 00:00 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director Ling Gabriel

Dec 28, 2023 00:00 ET

The Oncology Institute | 4: Statement of changes in beneficial ownership of securities-Director McGeorge Anne

Dec 28, 2023 00:00 ET